M. D. Giulia

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

S. Barni, R. Maria, G. Ciliberto, 2017, Oncotarget.

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

F. Cognetti, A. Lombardi, G. Atlante, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

S. Barni, R. Maria, G. Ciliberto, 2017, Oncotarget.

Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a

G. Rasi, G. Bonsignore, E. Garaci, 1995 .

Thymosin α1 and α-Inteferon with Cisplatin and Etoposide in Advanced Non-Small-Cell Lung Cancer: A Phase II Study

G. Bonsignore, E. Garaci, P. Vici, 1993 .

A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer

G. Atlante, F. Calabresi, M. Nardi, 1996, Cancer Chemotherapy and Pharmacology.

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer

G. Ciliberto, P. Vici, L. Pizzuti, 2019, Medicine.